Dr. Sulaiman Al-Habib Medical Services Group Co. () Stock Analysis

Price Point

High/Low

1Day

52 Week

Valuation

Technical

Day's Volume

CASH

N/A

Shareholding

FII

N/A

DII

N/A

Promoter

N/A

Score

Click here to find our call on this stock

Strong Sell

Sell

Hold

Buy

Strong Buy

MarketsMojo — Loved in India, Now Global

The power of Mojo is now in 29 countries. Explore global equities with the same cutting-edge features you love.Unlock 29 Markets

Dashboard

High Debt Company with a Debt to Equity ratio (avg) at times

Poor long term growth as Net Sales has grown by an annual rate of 18.68% and Operating profit at 19.53% over the last 5 years
High Debt Company with a Debt to Equity ratio (avg) at times
The company has been able to generate a Return on Equity (avg) of 28.79% signifying low profitability per unit of shareholders funds

Flat results in Jun 25

With ROE of 32.27%, it has a very attractive valuation with a 13.03 Price to Book Value

Mojo Parameters

Stock DNA

Industry

Hospital

Market cap

SAR 90,300 Million (Small Cap)

P/E

40.00

Industry P/E

Dividend Yield

1.36%

Debt Equity

0.86

Return on Equity

31.76%

Price to Book

11.75

Revenue and Profits:

Net Sales:

3,384 Million

(Quarterly Results - Jun 2025)

Net Profit:

602 Million

Total Returns

Total Returns (Price + Dividend)

TimePeriod

Price Return

Dividend Return

Total Return

3 Months

0.16%

6 Months

5.42%

1 Year

-14.81%

2 Years

-8.73%

3 Years

12.05%

4 Years

52.04%

5 Years

123.89%

Dr. Sulaiman Al-Habib Medical Services Group Co. for the last several years.

Risk Adjusted Returns v/s

News & Corporate Actions

News

No Recent News for the Company

Announcements

No announcement available

Corporate Actions

No corporate action available

Key Factors

Quality key factors

Factor

Value

Sales Growth (5y)

18.68%

EBIT Growth (5y)

19.53%

EBIT to Interest (avg)

28.76

Debt to EBITDA (avg)

0.70

Net Debt to Equity (avg)

0.78

Sales to Capital Employed (avg)

0.80

Tax Ratio

1.56%

Dividend Payout Ratio

72.11%

Pledged Shares

Institutional Holding

ROCE (avg)

24.09%

ROE (avg)

28.79%

Valuation key factors

Factor

Value

P/E Ratio

Industry P/E

Price to Book Value

13.03

EV to EBIT

41.34

EV to EBITDA

33.80

EV to Capital Employed

7.45

EV to Sales

8.23

PEG Ratio

4.92

Dividend Yield

0.83%

ROCE (Latest)

18.02%

ROE (Latest)

32.27%

Technicals key factors

Indicator

Weekly

Monthly

MACD

Bearish

RSI

No Signal

Bollinger Bands

Bearish

Mildly Bearish

Moving Averages

Bearish (Daily)

KST

Bullish

Bearish

Dow Theory

Mildly Bullish

No Trend

OBV

Mildly Bearish

Mildly Bullish

Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned

Shareholding

Shareholding Snapshot

No data for shareholding present.

Shareholding Compare (%holding)

No data for shareholding present.

Financial

[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "header": "Quarterly Results Snapshot (Consolidated) - Jun'25 - YoY",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in quarter ended Jun 2025 is 31.50% vs 13.26% in Jun 2024",
        "dir": 1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in quarter ended Jun 2025 is 7.36% vs 12.42% in Jun 2024",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Jun'25",
        "Jun'24",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "3,384.30",
          "val2": "2,573.60",
          "chgp": "31.50%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "808.20",
          "val2": "644.10",
          "chgp": "25.48%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "83.40",
          "val2": "23.00",
          "chgp": "262.61%",
          "chgp_class": "negative"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "602.40",
          "val2": "561.10",
          "chgp": "7.36%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "190.50%",
          "val2": "214.40%",
          "chgp": "-2.39%",
          "chgp_class": "negative"
        }
      ]
    }
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Consolidated) - Dec'24",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in year ended Dec 2024 is 17.79% vs 14.41% in Dec 2023",
        "dir": 1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in year ended Dec 2024 is 12.78% vs 24.43% in Dec 2023",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Dec'24",
        "Dec'23",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "11,200.40",
          "val2": "9,508.40",
          "chgp": "17.79%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "2,793.80",
          "val2": "2,422.10",
          "chgp": "15.35%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "179.50",
          "val2": "83.90",
          "chgp": "113.95%",
          "chgp_class": "negative"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "2,370.00",
          "val2": "2,101.50",
          "chgp": "12.78%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "211.90%",
          "val2": "221.80%",
          "chgp": "-0.99%",
          "chgp_class": "negative"
        }
      ]
    }
  }
]

Quarterly Results Snapshot (Consolidated) - Jun'25 - YoY

Jun'25

Jun'24

Change(%)

Net Sales

3,384.30

2,573.60

31.50%

Operating Profit (PBDIT) excl Other Income

808.20

644.10

25.48%

Interest

83.40

23.00

262.61%

Exceptional Items

0.00

Consolidate Net Profit

602.40

561.10

7.36%

Operating Profit Margin (Excl OI)

190.50%

214.40%

-2.39%

USD in Million.

Compare with Peers

Net Sales

YoY Growth in quarter ended Jun 2025 is 31.50% vs 13.26% in Jun 2024

Consolidated Net Profit

YoY Growth in quarter ended Jun 2025 is 7.36% vs 12.42% in Jun 2024

All Quarterly Results

Annual Results Snapshot (Consolidated) - Dec'24

Dec'24

Dec'23

Change(%)

Net Sales

11,200.40

9,508.40

17.79%

Operating Profit (PBDIT) excl Other Income

2,793.80

2,422.10

15.35%

Interest

179.50

83.90

113.95%

Exceptional Items

0.00

Consolidate Net Profit

2,370.00

2,101.50

12.78%

Operating Profit Margin (Excl OI)

211.90%

221.80%

-0.99%

USD in Million.

Compare with Peers

Net Sales

YoY Growth in year ended Dec 2024 is 17.79% vs 14.41% in Dec 2023

Consolidated Net Profit

YoY Growth in year ended Dec 2024 is 12.78% vs 24.43% in Dec 2023

All Annual Results

Company CV

About Dr. Sulaiman Al-Habib Medical Services Group Co.

Dr. Sulaiman Al-Habib Medical Services Group Co.

Hospital

No Details Available.

Company Coordinates

No Company Details Available